In an opinion piece in the Guardian’s “Comment is Free” blog, Dean Baker, co-director of the Center for Economic and Policy Research, discusses potential policies contained within the “Trans-Pacific Partnership Agreement (TPP), a pact that the United States is negotiating with Australia, Canada, Japan and eight other countries in the Pacific region.” However, “[a]t this point, it’s not really possible to discuss the merits of the TPP since the governments are keeping the proposed text a secret from the public,” he says. Noting “[a] few items that have been leaked give us some insight as to the direction of this pact,” he discusses how the “pharmaceutical industry is … likely to be a big gainer” from the TPP if the pact includes “stronger and longer patent protection and also increased use of ‘data exclusivity.'”
Access to Health Services
At the opening ceremony of World Water Week in Stockholm, Sweden, on Monday, the Food and Agriculture Organization (FAO) “launched a framework that will help combat food insecurity by providing methods to better manage water resources in agriculture and reduce waste,” the U.N. News Centre reports. “The initiative, entitled ‘Coping with water scarcity: An action framework for agriculture and food security’ [.pdf], seeks to encourage practices that will improve water management, such as modernizing irrigation schemes, recycling and re-using wastewater, implementing mechanisms to reduce water pollution, and storing rainwater at farms to reduce drought-related risks, among others,” the news service notes.
Highlighting a recent report by the Journal of the Royal Society of Medicine about the use of the drug misoprostol to prevent postpartum hemorrhage and the WHO’s inclusion of the drug on its Essential Medicine List, Guardian health editor Sarah Boseley writes in this post in her “Global Health Blog,” “Seldom has there been a drug that has excited as much controversy as misoprostol.” She continues, “Misoprostol causes the uterus to contract, which is why it can stop postpartum hemorrhage, the cause of around a quarter of maternal deaths,” but “there has been a huge fight over whether and how well it works, which in some quarters has been ideologically motivated, because misoprostol can also bring about an abortion.”
Dominican Republic Establishes Commission To Examine Implications Of Including ART In Country Health Plan
“The Dominican Republic is one step closer to ensuring that all people living with HIV access treatment,” UNAIDS reports in an article on its webpage, adding, “The country’s National Social Security Council has established a commission to look into the technical, financial and operational implications of including antiretroviral therapy (ART) in the Basic Health Plan.” According to the article, “[t]he establishment of the commission comes after a financial feasibility study about covering people living with HIV under the country’s family health insurance,” and “[t]he newly-established commission — whose membership includes several national health system offices in addition to regional and global partners such as PAHO and UNAIDS — is set to complete its work during the last quarter of 2012” (8/23).
In this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Max Kamin-Cross, a self-proclaimed political junky and youth activist, writes that by improving access to contraceptives, “[w]e could lift millions of people of all races and both genders out of poverty throughout the world,” “we could significantly decrease the number of premature deaths, as well as the number of lives claimed by deadly infections like HIV,” and “the quality of life for millions more people would be drastically improved.” He provides statistics regarding access to contraception and continues, “This issue should not be controversial. The future of my generation truly may rely on the fate of contraceptive access” (8/22).
One Blog Examines GAVI Alliance's Efforts To Accelerate Introduction Of Hepatitis B Vaccines In Developing Countries
“I am looking forward to participating in the 2012 World Cancer Leaders’ Summit, to be held in Montreal, Canada on August 27,” GAVI Alliance Deputy CEO Helen Evans writes in this post in the One Blog. “This will be an opportunity to take stock of where the world is with regards to cancer prevention and treatment and to learn more about action to address the existing challenges to eliminating cancer as a life-threatening disease for future generations,” she writes, and discusses GAVI’s efforts to “accelerat[e] the introduction of hepatitis B vaccines in developing countries since 2000,” noting “GAVI has helped prevent an estimated 3.7 million deaths from liver cancer (caused by hepatitis B)” (8/21).
“India’s top court will hear final arguments … in a key patent dispute between Swiss drug maker Novartis and India’s patent office, a case that could curb India’s global position as a supplier of cut-price generic medicines,” Reuters reports. “Novartis appealed to the Supreme Court after its cancer medicine Glivec was refused a patent on the grounds the drug is not a new molecule but an amended version of a known compound,” the news service notes, adding, “Novartis has challenged this clause of Indian Patents Act.”
African Development Bank Report Compares, Analyzes African Countries' Performance In Water, Sanitation Sector
“[A]ccording to a new African Development Bank report that compares and analyzes the performance of sub-Saharan African countries in the water and sanitation sector,” “the two major factors why progress on meeting water and sanitation-related development goals across sub-Saharan Africa is largely uneven” are “[d]ifferences in financial and operational capacities among governments,” the Devex “Development Newswire” reports. Specifically, the “factors the report says affect the sub-Saharan African countries’ progress toward the United Nations-set targets on sanitation and access to water” include “[u]nderstaffing and lack of technical qualification in relevant government agencies,” “[l]ack of adequate operation and maintenance programs in donor-financed projects,” and “[i]nadequate national capacities to implement national strategies,” the news service writes.
“Ethiopia is preparing for a flood of medical doctors within ‘three to four years,’ an influx meant to save a public health system that has been losing doctors and specialists to internal and external migration,” IRIN reports. “‘We are now implementing strategies that intend to increase the current below-World Health Organization [WHO] standard number of medical doctors and retaining them in public hospitals,’ Tedros Adhanom, Ethiopia’s minister of health, told IRIN,” the news service writes. “‘We have now reached an enrollment rate of more than 3,100,’ [Adhanom] said,” adding, “The rate of enrollment in the country’s medical schools has increased tenfold from 2005, when it was below 300,” according to the news service.
In this post in Huffington Post’s “Healthy Living” blog, John-Manuel Andriote, a journalist and author living with HIV, writes, “For all of us living with HIV infection — Oct. 27 will mark seven years since my own diagnosis — the question we face daily, hopefully more consciously and deliberately than most, is how shall we live, knowing as we do that we will most assuredly die one day?” Reflecting on the XIX International AIDS Conference (AIDS 2012) that took place in Washington last month, he continues, “An AIDS-free generation is certainly a worthy goal,” but “even if tens of billions of additional dollars are allocated to address HIV/AIDS, even if the Republicans don’t succeed in inflicting their Darwinian ‘survival of the fittest’ upon the nation and the world, the question will continue to be what it has been for 31 years … Will we have the political will to end AIDS?”